Elvin Blanco

Author PubWeight™ 16.31^‹?›

Top papers

Rank	Title	Journal	Year	PubWeight™‹?›
1	Functionalized micellar systems for cancer targeted drug delivery.	Pharm Res	2007	1.90
2	Enabling individualized therapy through nanotechnology.	Pharmacol Res	2010	1.28
3	Multi-stage delivery nano-particle systems for therapeutic applications.	Biochim Biophys Acta	2010	1.23
4	Polymer implants for intratumoral drug delivery and cancer therapy.	J Pharm Sci	2008	1.09
5	Antitumor efficacy and local distribution of doxorubicin via intratumoral delivery from polymer millirods.	J Biomed Mater Res A	2007	1.05
6	Inhibition of iNOS as a novel effective targeted therapy against triple-negative breast cancer.	Breast Cancer Res	2015	1.04
7	Intratumoral delivery of beta-lapachone via polymer implants for prostate cancer therapy.	Clin Cancer Res	2009	1.04
8	Folate-functionalized polymeric micelles for tumor targeted delivery of a potent multidrug-resistance modulator FG020326.	J Biomed Mater Res A	2008	1.00
9	Combined radiofrequency ablation and doxorubicin-eluting polymer implants for liver cancer treatment.	J Biomed Mater Res A	2007	0.97
10	Modulating beta-lapachone release from polymer millirods through cyclodextrin complexation.	J Pharm Sci	2006	0.95
11	Proteomic analysis of serum opsonins impacting biodistribution and cellular association of porous silicon microparticles.	Mol Imaging	2011	0.92
12	Model simulation and experimental validation of intratumoral chemotherapy using multiple polymer implants.	Med Biol Eng Comput	2008	0.85
13	Gadolinium metallofullerenol nanoparticles inhibit cancer metastasis through matrix metalloproteinase inhibition: imprisoning instead of poisoning cancer cells.	Nanomedicine	2011	0.85
14	Chloroquine eliminates cancer stem cells through deregulation of Jak2 and DNMT1.	Stem Cells	2014	0.84
15	The physiology of cardiovascular disease and innovative liposomal platforms for therapy.	Int J Nanomedicine	2013	0.81
16	Mass partitioning effects in diffusion transport.	Phys Chem Chem Phys	2015	0.75
17	Nanoparticle-based polychemotherapy: optimizing drug synergy for efficacious cancer treatment.	Ther Deliv	2014	0.75